7,376.86

+23.13

+0.31%

51,285.73

-237.37

-0.46%

24,579.42

+264.42

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,797.99

+213.39

+0.28%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

OTC Markets OTCQB - Delayed Quote USD

Biotricity, Inc. (BTCY)

0.0560 +0.0039 (+7.49%)

At close: November 6 at 4:00:00 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Biotricity, Inc to Present at the LD Micro Invitational XVI

TMX Newsfile 5mo ago

BTCY
+7.49%
Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...

GuruFocus.com 8mo ago

BTCY
+7.49%
Q2 Investor Summit Virtual Live Wednesday June 24

ACCESS Newswire 4mo ago
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

GlobeNewswire 8mo ago

BTCY
+7.49%
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th

GlobeNewswire 8mo ago

BTCY
+7.49%
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health

Zacks 10mo ago

HIMS

PRVA

BTCY
+7.49%
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run

Zacks 10mo ago

BTCY
+7.49%
HIMS
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026

GlobeNewswire 11mo ago

BTCY
+7.49%
Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates

Zacks 11mo ago

FATE

BTCY
+7.49%
Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates

Zacks 11mo ago

LUNG

BTCY
+7.49%

Performance Overview

Return	BTCY	S&P 500 (^GSPC)
YTD	-81.33%	+7.76%
1-Year	-90.17%	+9.77%
3-Year	-94.11%	+68.96%

Mobilize your Website

View Site in Mobile | Classic

Share by: